Miromatrix Medical Inc. (MIRO)

$2.75

+0.11 (+4.17%)
Rating:
Recommendation:
-
Symbol MIRO
Price $2.75
Beta 0.000
Volume Avg. 0.02M
Market Cap 56.907M
Shares () -
52 Week Range 2.02-12.84
1y Target Est -
DCF Unlevered MIRO DCF ->
DCF Levered MIRO LDCF ->
ROE -38.24% Strong Sell
ROA -39.74% Strong Sell
Operating Margin -
Debt / Equity 13.70% Neutral
P/E -
P/B 1.18 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest MIRO news


Dr. Jeff Ross Ph.D.
Healthcare
Biotechnology
NASDAQ Capital Market

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.